Ultrasound and the blood-brain barrier

Adv Exp Med Biol. 1990:267:369-81. doi: 10.1007/978-1-4684-5766-7_36.

Abstract

High intensity focused ultrasound was employed to modify the permeability of the normal feline and canine blood-brain barrier (BBB) to a circulating vital dye--Evans blue (EB). The threshold doses (W sec/cm2) for focally increasing the permeability of the BBB in white matter (WM) and gray matter (GM) were as follows: internal capsule (WM)--340 to 680; thalamus (GM)--approximately 1326; and caudate nucleus (GM)--2284 to 2952. In the presence of supralesioning doses of ultrasound, the cross sectional area occupied by the EB was consistently greater than that of the attendant nonhemorrhagic lesion--thus suggesting that BBB changes may be inducible at sublesioning doses. These findings, in conjunction with those of others, suggest that high intensity focused ultrasound may have a role in the treatment of brain tumors based on cell destruction by two mechanisms: (a) direct, by the ultrasound and (b) indirect, by an antineoplastic agent which is delivered via an ultrasonically modified BBB.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Basal Ganglia / anatomy & histology
  • Basal Ganglia / metabolism
  • Blood-Brain Barrier / physiology*
  • Brain Neoplasms / therapy
  • Cats
  • Caudate Nucleus / anatomy & histology
  • Caudate Nucleus / metabolism
  • Dogs
  • Evans Blue / pharmacokinetics
  • Permeability
  • Stereotaxic Techniques
  • Thalamus / anatomy & histology
  • Thalamus / metabolism
  • Time Factors
  • Ultrasonic Therapy*
  • Ultrasonics

Substances

  • Evans Blue